Pharmaceutical companies have a unique challenge of ensuring compliance and internal approvals across distributed manufacturing locations for the purposes of Drug Audits. Convention paper based approvals have resulted in huge compliance failures sometimes resulting in multi million dollar lawsuits.
Legally Valid Digital Signatures offer an ideal use case for going paperless for completely eliminating paper while ensuring full compliance, auditability and traceability for every single process right from clinical trials to roll out of a new drug.
Paperless Office Transformation
eMudhra’s paperless office solution emSigner works on the cloud to transform customer, supplier, internal workflows to completely paperless ones using Digital Signatures. emSigner is designed to allow customized workflow definitions, multi party signatures, sequential or parallel signing, encryption.
For pharma companies, customized workflows can be configured by emSigner for departments mapped with the company authorization matrix such as
- Employees – Internal paper approvals in production facilities, plants can be digitally signed based on authorization matrix
- Human Resources – for issuing and accepting digitally signed offer letters, performance appraisals, tax statements to employees
- Finance – for issuing and accepting Purchase Orders, Invoices from Vendors and to Customers
- Legal – Digitally signed contracts can be initiated and sent to other parties for signatures
Stakeholders can use legally valid transaction based digital signatures which are can be generated either server side or in a crypto token to review and sign approvals to complete the workflow. The documents are encrypted and stored in an inbuilt Document Vault. The documents are archived based on regulations for easy future retrieval.
Using emSigner results in huge cost savings, compliance and improved customer experience for Pharma companies. For more information, please click here to go to emSigner site.